Zusammenfassung
Hypertensive Erkrankungen beeinflussen ca. 10% aller Schwangerschaften und sind somit eine der Hauptursachen für maternale und fetale Morbidität und Mortalität. Das Spektrum hypertensiver Erkrankungen in der Schwangerschaft umfasst die Präeklampsie mit den schweren Verlaufsformen Eklampsie und HELLP-Syndrom, die chronische Hypertonie, die Gestationshypertonie inklusive der Pfropfgestose und die pulmonale Hypertonie. In dieser Übersichtsarbeit werden die genannten Diagnosen hypertensiver Erkrankungen in der Schwangerschaft mit den derzeit aktuellen Therapieoptionen aus interdisziplinärer Sicht vorgestellt.
Abstract
Hypertension affects about 10% of pregnancies and is a leading cause of both maternal and fetal morbidity and mortality worldwide. Hypertension in pregnancy includes a spectrum of conditions, including preeclampsia or eclampsia, chronic arterial hypertension, gestational hypertension, and pulmonary hypertension. In this review article, current data and recommendations are summarized regarding definitions, diagnoses, and treatment options for hypertensive disorders in pregnancy.
Literatur
American Academy of Pediatrics Committee on Drugs (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93: 137–150
Barton JR, O’Brien JM, Bergauer NK et al. (2001) Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184: 979–983
Beardmore KS, Morris JM, Gallery ED (2002) Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 21: 85–95
Bonnin M, Mercier FJ, Sitbon O et al. (2005) Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102: 1133–1137
Brown MA, Lindheimer MD, de Swiet M et al. (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX–XIV
Brown MA, Hague WM, Higgins J et al. (2000) The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol 40: 139–155
Collins R, Yusuf S, Peto R (1985) Overview of randomised trials of diuretics in pregnancy. BMJ 290: 17–23
Cooper WO, Hernandez-Diaz S, Arbogast PG (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354: 2443–2451
Cunningham FG, Lindheimer MD (1992) Hypertension in pregnancy. N Engl J Med 326: 927–932
Frishman WH, Schlocker SJ, Awad K, Tejani N (2005) Pathophysiology and medical management of systemic hypertension in pregnancy. Cardiol Rev 13: 274–284
Galie N, Manes A, Farahani KV et al. (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14: 713–717
Girndt J (2003) Hochdruck und hypertensiver Notfall in der Schwangerschaft. Herz 28: 185–195
Gohlke-Barwolf CE, Eichstaedt, H (2004) Herzerkrankungen und Schwangerschaft. In: Roskamm N, Kalusche, Bestehorn H (Hrsg) Herzerkrankungen. Springer, Berlin Heidelberg New York
Greene MF (2003) Magnesium sulfate for preeclampsia. N Engl J Med 348: 275–276
Gruppo GdSIiG (1998) Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. Br J Obstet Gynaecol 105: 718–722
Hogstedt S (1985) A propective controlled trial of metoprolol-hydralazine treatment of hypertension during pregnancy. Acta Obstet Gynecol Scand 64: 505–510
James PR, Nelson-Piercy C (2004) Management of hypertension before, during, and after pregnancy. Heart 90: 1499–1504
Klein HH, Pich S (2003) Cardiovascular changes during pregnancy. Herz 28: 173–174
Magee LA, Ornstein MP, von Dadelszen P (1999) Fortnightly review: management of hypertension in pregnancy. BMJ 318: 1332–1336
Magee LA, Duley L (2003) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev: CD002863
Magee LA, Schick B, Donnenfeld AE et al. (1996) The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174: 823–828
Magee LA, Cham C, Waterman EJ et al. (2003) Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 327: 955–960
Magee L, Sadeghi S (2005) Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev: CD004351
National High Blood Pressure Education Program Working Group NWG (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183: 1-22
Oakley C, Child A, Iung B et al. (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24: 761–781
Page RL (1995) Treatment of arrhythmias during pregnancy. Am Heart J 130: 871–876
Presbitero P, Prever SB, Aruta E (1995) The Eisenmenger syndrome. Is it still a problem for the cardiologist in adults? G Ital Cardiol 25: 89–94
Rath W (2005) Hypertensive Schwangerschaftserkrankungen. In: Rath W, Friese K (Hrsg) Erkrankungen in der Schwangerschaft. Thieme, Stuttgart, S 73–97
Rath W, Heilmann L, Faridi A, Klockenbusch W (2002) Empfehlungen zur Diagnostik und Therapie des Bluthochdrucks in der Schwangerschaft. Frauenarzt 43: 847–851
Redman CW (1991) Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 17: 149–153
Reynolds B, Butters L, Evans J (1984) First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child 59: 1061–1063
Shotan A, Widerhorn J, Hurst A, Elkayam U (1994) Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 96: 451–456
Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335: 257–265
Sibai BM (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100: 369–377
Sibai BM, Barton JR, Akl S (1992) A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 167: 879–884
Siu SC, Sermer M, Harrison DA et al. (1997) Risk and predictors for pregnancy- related complications in women with heart disease. Circulation 96: 2789–2794
Steer PJ, Little MP, Kold-Jensen T et al. (2004) Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 329: 1312
Thorne SA (2004) Pregnancy in heart disease. Heart 90: 450–456
von Dadelszen P, Ornstein MP, Bull SB et al. (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355: 87–92
Walker JJ (2000) Pre-eclampsia. Lancet 356: 1260–1265
Weiss BM, Hess OM (2000) Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 21: 104–115
Weiss BM, Zemp L, Seifert B, Hess OM (1998) Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31: 1650–1657
Weiss BM, von Segesser LK, Alon E et al. (1998) Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 179: 1643–1653
Yentis SM, Steer PJ, Plaat F (1998) Eisenmenger’s syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 105: 921–922
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thäle, V., Schlitt, A. Hypertensive Erkrankungen in der Schwangerschaft. Internist 49, 811–816 (2008). https://doi.org/10.1007/s00108-008-2069-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-008-2069-0